Downregulation of CCR5 Expression on the Peripheral Blood CD8+ T Cells of Southeastern Iranian Patients with Chronic Hepatitis B Infection
暂无分享,去创建一个
H. Khodadadi | M. Arababadi | R. Pourali | D. Kennedy | G. Hassanshahi | B. N. Ahmadabadi | V. Mirzaei | H. Khoramdelazad | S. Sajadi | Masomeh Hajghani
[1] P. Pumpens,et al. T helper and B cell escape mutations within the HBc gene in patients with asymptomatic HBV infection: a study from the South-Eastern region of Iran. , 2012, Clinical laboratory.
[2] Z. Herceg,et al. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. , 2011, Mutation research.
[3] M. Arababadi,et al. Evaluation of CCR5 Expression on NK Cells in Iranian Patients With Occult Hepatitis B Infection , 2010 .
[4] M. Arababadi,et al. Peripheral Blood CD8 + T Cells CCR5 Expression and Its Δ32 Mutation in Iranian Patients with Occult Hepatitis B Infections , 2010 .
[5] Jie Zhou,et al. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population , 2010, Journal of medical virology.
[6] M. Arababadi,et al. No association between CCR5-Δ32 mutation and multiple sclerosis in patients of Southeastern Iran , 2010 .
[7] M. Arababadi,et al. Is CCR5-Δ32 mutation associated with diabetic nephropathy in type 2 diabetes? , 2009, Annals of Saudi medicine.
[8] Sukriti,et al. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection , 2009, Hepatology.
[9] M. Massari,et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection , 2009, Gut.
[10] E. Fish,et al. Role for CCR5 in Dissemination of Vaccinia Virus In Vivo , 2008, Journal of Virology.
[11] P. Tien,et al. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope. , 2007, Clinical immunology.
[12] Y. Paik,et al. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea , 2006, Journal of medical virology.
[13] M. Swain,et al. CCR5 in T Cell-Mediated Liver Diseases: What’s Going On?1 , 2006, The Journal of Immunology.
[14] J. Schwartzman,et al. CCR5 Is Essential for NK Cell Trafficking and Host Survival following Toxoplasma gondii Infection , 2006, PLoS pathogens.
[15] S. Sarin,et al. Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease , 2006 .
[16] P. Sharp,et al. Involvement of CCR5 in the passage of Th1‐type cells across the blood‐retina barrier in experimental autoimmune uveitis , 2006, Journal of leukocyte biology.
[17] S. Sarin,et al. Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. , 2006, Journal of hepatology.
[18] S. Ahn,et al. [Association between CCR5 promoter polymorphisms and hepatitis B virus infection]. , 2005, The Korean journal of hepatology.
[19] M. Kuroda,et al. HBcAg-Specific CD8 T Cells Play an Important Role in Virus Suppression, and Acute Flare-Up Is Associated with the Expansion of Activated Memory T Cells , 2003, Journal of Clinical Immunology.
[20] K. Han,et al. [Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection]. , 2002, Taehan Kan Hakhoe chi = The Korean journal of hepatology.